Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 5/2021

01-10-2021 | Endoscopy | Case Report

Mesenteric phlebosclerosis associated with the oral intake of Japanese traditional (Kampo) medicines containing Gardeniae Fructus

Authors: Etsuko Hisanaga, Takaaki Sano, Keigo Sato, Shiko Kuribayashi, Toshio Uraoka

Published in: Clinical Journal of Gastroenterology | Issue 5/2021

Login to get access

Abstract

We report a case of mesenteric phlebosclerosis (MP) in a woman in her 50s who had been taking Kamishoyosan for 13 years. Colonoscopic findings 13 years after the start of oral administration were nonspecific, with decreased vascular permeability and redness of the mucosa. The extent of the lesion was initially from the cecum to the ascending colon but expanded over time to the transverse colon. In colon biopsies, there was a remarkable deposition of collagen fibers around the small vessels in the lamina propria of the cecum or the ascending colon over time, and the specific lesions expanded to the transverse colon. The deposition of collagen fibers around the vessels in the lamina propria was already present when the total oral dose of the Sanshishi component was low. In this valuable case of MP, changes after the start of oral administration of Kamishoyosan could be followed over time via endoscopy and biopsy.
Literature
1.
go back to reference Iwashita A, Yao T, Schlemper RJ, et al. Mesenteric phlebosclerosis: a new disease entity causing ischemic colitis. Dis Colon Rectum. 2003;46:209–20.CrossRef Iwashita A, Yao T, Schlemper RJ, et al. Mesenteric phlebosclerosis: a new disease entity causing ischemic colitis. Dis Colon Rectum. 2003;46:209–20.CrossRef
2.
go back to reference Hiramatsu K, Sakata H, Horita Y, et al. Mesenteric phlebosclerrosis associated with long-term oral intake of geniposide, an ingredient of herbal medicine. Aliment Pharmacol Ther. 2012;36:575–86.CrossRef Hiramatsu K, Sakata H, Horita Y, et al. Mesenteric phlebosclerrosis associated with long-term oral intake of geniposide, an ingredient of herbal medicine. Aliment Pharmacol Ther. 2012;36:575–86.CrossRef
3.
go back to reference Nagata Y, Watanabe T, Nagasaka K, et al. Clinical search for undiagnosed mesenteric phlebosclerosis at outpatient departments specializing in herbal (Kampo) medicine. Intern Med. 2016;55:573–81.CrossRef Nagata Y, Watanabe T, Nagasaka K, et al. Clinical search for undiagnosed mesenteric phlebosclerosis at outpatient departments specializing in herbal (Kampo) medicine. Intern Med. 2016;55:573–81.CrossRef
4.
go back to reference Ohtsu K, Matsui T, Nishimura T, et al. Association between mesenteric phlebosclerosis and Chinese herbal medicine intake. Nihon Shokakibyo Gakkai Zasshi. 2014;111:61–8.PubMed Ohtsu K, Matsui T, Nishimura T, et al. Association between mesenteric phlebosclerosis and Chinese herbal medicine intake. Nihon Shokakibyo Gakkai Zasshi. 2014;111:61–8.PubMed
5.
go back to reference Ding J, Zhang W, Wang L, et al. Idiopathic mesenteric phlebosclerosis: clinical and CT imaging characteristics. Quant Imaging Med Surg. 2021;11:763–71.CrossRef Ding J, Zhang W, Wang L, et al. Idiopathic mesenteric phlebosclerosis: clinical and CT imaging characteristics. Quant Imaging Med Surg. 2021;11:763–71.CrossRef
6.
go back to reference Xu J, Jiang Z, Ke Q, et al. Clinicopathological features of phlebosclerotic colitis. Pathol Res Pract. 2020;216:153193.CrossRef Xu J, Jiang Z, Ke Q, et al. Clinicopathological features of phlebosclerotic colitis. Pathol Res Pract. 2020;216:153193.CrossRef
7.
go back to reference Yoshinaga S, Nakamura K, Harada N, et al. Clinical practice (clinical picture) of idiopathic mesenteric venous sclerosis. Stomach Intest. 2009;44:163–9. Yoshinaga S, Nakamura K, Harada N, et al. Clinical practice (clinical picture) of idiopathic mesenteric venous sclerosis. Stomach Intest. 2009;44:163–9.
8.
go back to reference Kubo K, Kimura N, Maiya N, et al. Mesenteric phlebosclerosis associated with herbal medicine. Case Rep Gastroenterol. 2020;14:516–21.CrossRef Kubo K, Kimura N, Maiya N, et al. Mesenteric phlebosclerosis associated with herbal medicine. Case Rep Gastroenterol. 2020;14:516–21.CrossRef
9.
go back to reference Sasaki Y, Saito M, Koshiba Y, et al. Idiopathic mesenteric phlebosclerosis associated with herbal drugs presenting with asymptomatic fecal occult blood. J Gen Fam Med. 2017;18:475–6.CrossRef Sasaki Y, Saito M, Koshiba Y, et al. Idiopathic mesenteric phlebosclerosis associated with herbal drugs presenting with asymptomatic fecal occult blood. J Gen Fam Med. 2017;18:475–6.CrossRef
10.
go back to reference Minami K, Fujiie M, Fushimi F, et al. Ascending colon cancer coincident with mesenteric phlebosclerosis associated with the long-term oral intake of Chinese herb containing gardenia fruit: a case report and literature review. Int Cancer Conf J. 2017;6:70–5.CrossRef Minami K, Fujiie M, Fushimi F, et al. Ascending colon cancer coincident with mesenteric phlebosclerosis associated with the long-term oral intake of Chinese herb containing gardenia fruit: a case report and literature review. Int Cancer Conf J. 2017;6:70–5.CrossRef
11.
go back to reference Wen Y, Zhao M, Huang W, et al. Idiopathic mesenteric phlebosclerosis associated with use of Chinese herbal medicine. Medicine. 2020;99:e22813.CrossRef Wen Y, Zhao M, Huang W, et al. Idiopathic mesenteric phlebosclerosis associated with use of Chinese herbal medicine. Medicine. 2020;99:e22813.CrossRef
12.
go back to reference Hoshino N, Hasegawa S, Hida K, et al. Right hemicolectomy for mesenteric phlebosclerosis potentially caused by long-term use of herbal medicine: a case report and literature review. Int J Surg Case Rep. 2016;24:191–4.CrossRef Hoshino N, Hasegawa S, Hida K, et al. Right hemicolectomy for mesenteric phlebosclerosis potentially caused by long-term use of herbal medicine: a case report and literature review. Int J Surg Case Rep. 2016;24:191–4.CrossRef
13.
go back to reference Shimizu S, Kobayashi T, Tomioka H, et al. Involvement of herbal medicine as a cause of mesenteric phlebosclerosis: results from a large-scale nationwide survey. J Gastroenterol. 2017;52:308–14.CrossRef Shimizu S, Kobayashi T, Tomioka H, et al. Involvement of herbal medicine as a cause of mesenteric phlebosclerosis: results from a large-scale nationwide survey. J Gastroenterol. 2017;52:308–14.CrossRef
14.
go back to reference Yi-Bing Hu, Min-Li Hu, Ding J, et al. Mesenteric phlebosclerosis with amyloidosis in association with the long-term use of medicinal liquor: a case report. World J Clin Cases. 2020;8:798–805.CrossRef Yi-Bing Hu, Min-Li Hu, Ding J, et al. Mesenteric phlebosclerosis with amyloidosis in association with the long-term use of medicinal liquor: a case report. World J Clin Cases. 2020;8:798–805.CrossRef
15.
go back to reference Lee SM, Seo JW. Phlebosclerotic colitis: case report of literature review focused on the radiologic findings in relation to the intake period of toxic material. Jpn J Radiol. 2015;33:663–7.CrossRef Lee SM, Seo JW. Phlebosclerotic colitis: case report of literature review focused on the radiologic findings in relation to the intake period of toxic material. Jpn J Radiol. 2015;33:663–7.CrossRef
16.
go back to reference Nagata Y, Watanabe T, Nagasaka K, et al. Total dosage of gardenia fruit used by patients with mesenteric phlebosclerosis. BMC Complement Altern Med. 2016;16:207–17.CrossRef Nagata Y, Watanabe T, Nagasaka K, et al. Total dosage of gardenia fruit used by patients with mesenteric phlebosclerosis. BMC Complement Altern Med. 2016;16:207–17.CrossRef
Metadata
Title
Mesenteric phlebosclerosis associated with the oral intake of Japanese traditional (Kampo) medicines containing Gardeniae Fructus
Authors
Etsuko Hisanaga
Takaaki Sano
Keigo Sato
Shiko Kuribayashi
Toshio Uraoka
Publication date
01-10-2021
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 5/2021
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-021-01490-8

Other articles of this Issue 5/2021

Clinical Journal of Gastroenterology 5/2021 Go to the issue